Bambusa Therapeutics Upsizes IPO with Pricing at $16 Per Share
Bambusa Therapeutics (BBTX) has priced its upsized initial public offering at $16 per share, representing a total of 10.56 million common shares. The company anticipates generating approximately $168.9 million in gross proceeds from the offering, prior to accounting for underwriting and offering expenses. The offering is being conducted entirely by Bambusa Therapeutics. Underwriters have been granted a 30-day option to purchase an additional 1.58 million shares at the initial IPO price. The company is scheduled to begin trading on the Nasdaq Global Select Market under the ticker symbol BBTX on October 30, 2026, with the offering expected to close on November 2, 2026.